---
document_datetime: 2023-09-21 22:02:21
document_pages: 6
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/desloratadine-actavis-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf
document_name: desloratadine-actavis-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 11.0250949
conversion_datetime: 2025-12-18 11:32:38.726226
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
## DesloratadineActavis

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                  | Opinion/ Notification 1 issued on   | Commission Decision Issued² / amended on   | Product Information affected3   | Summary                                                                                                  |
|----------------------|------------------------------------------------------------------------|-------------------------------------|--------------------------------------------|---------------------------------|----------------------------------------------------------------------------------------------------------|
| IG/1612              | A.1 - Administrative change - Change in the name and/oraddressoftheMAH | 31/05/2023                          |                                            | SmPC, Labelling and PL          |                                                                                                          |
| PSUSA/962/2 02107    | Periodic Safety Update EU Single assessment - desloratadine            | 24/03/2022                          | 30/05/2022                                 | SmPC and PL                     | Please refer to Aerius-Azomyr-Neoclarityn-Desloratadine Teva-Dasselta-DesloratadineActavis-Desloratadine |

1 Notifications are issued for type I variations and Article 61(3) notifications (unless part of a group including a type II variation or extension application or a worksharing application). Opinions areissuedforallotherprocedures.

3SmPC(Summary ofProductCharacteristics),AnnexII, Labelling,PL(Package Leaflet).

2A Commission decision(CD) is issued for procedures that affect the terms of the marketing authorisation(e.g.summary of product characteristics,annex II, labelling,package leaflet).The CD is issued within twomonths of the opinion for variations falling under the scope of Article 23.1a(a) of Regulation(EU) No.712/2012, or within one year for other procedures.

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

|             |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |            |            |                                  | ratiopharm-EMEA/H/C/PSUSA/00000962/202107EPAR: Scientificconclusionsandgroundsrecommending the variationtothetermsofthemarketingauthorisation   |
|-------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|----------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------|
| IAIN/0021/G | This was an applicationfor a group ofvariations. A.5.a-Administrative change -Change in the name and/oraddressof amanufacturer/importer responsible forbatchrelease B.II1.1.a.2-Submissionofanew/updatedor deletionofPh.Eur.CertificateofSuitabilitytothe relevantPh.Eur.Monograph-Updated certificate fromanalreadyapprovedmanufacturer A.7-Administrativechange-Deletion of manufacturingsites B.III.2.b - Change to comply with Ph. Eur. or with a nationalpharmacopoeiaof aMemberState-Change to comply with an update of the relevant monograph of thePh.Eur.ornationalpharmacopoeiaofa | 27/02/2022 | 30/05/2022 | SmPC, Annex II and PL            |                                                                                                                                                 |
| N/0019      | Minorchangeinlabellingorpackageleafletnot connectedwiththeSPC(Art.61.3Notification)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          | 29/09/2021 | 30/05/2022 | PL                               |                                                                                                                                                 |
| IB/0018     | C.I.2.a-Change in the SPC,Labelling or PL of a generic/hybrid/biosimilarproductsfollowing assessment of the same change for the reference product - Implementation of change(s) for which NO newadditional dataisrequiredtobesubmittedby the MAH                                                                                                                                                                                                                                                                                                                                             | 16/04/2020 | 29/01/2021 | SmPC, Annex II, Labelling and PL |                                                                                                                                                 |

<div style=\"page-break-after: always\"></div>

| IA/0017     | B.III.1.a.2 -Submission of a new/updated or deletion ofPh.Eur.Certificateof Suitability to the relevantPh.Eur.Monograph-Updated certificate from an already approvedmanufacturer                                                                                                                                                                                                                                                                                                      | 22/11/2019   | n/a        |                 |                                                          |
|-------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|-----------------|----------------------------------------------------------|
| IAIN/0016/G | This was an application for a group of variations. A.7-Administrativechange-Deletion of manufacturing sites B.II.b.1.a-Replacement or addition of a manufacturing sitefortheFp-Secondarypackaging site B.II.b.1.b-Replacement or addition of a manufacturing sitefor theFp-Primarypackaging site B.II.b.2.c.1-Change to importer,batch release arrangements and quality control testing of the FP - Replacementoradditionofamanufacturer responsibleforimportationand/orbatchrelease- | 08/08/2019   | 29/01/2021 | Annex II and PL |                                                          |
| N/0015      | Minor change inlabelling orpackageleaflet not connectedwiththeSPC(Art.61.3Notification)                                                                                                                                                                                                                                                                                                                                                                                               | 10/10/2018   | 29/01/2021 | PL              |                                                          |
| N/0014      | Minorchangeinlabellingorpackageleafletnot connected with the SPC(Art.61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                               | 21/03/2018   | 23/04/2018 | PL              |                                                          |
| IAIN/0013   | C.I.z - Changes (Safety/Efficacy) of Human and VeterinaryMedicinalProducts-Othervariation                                                                                                                                                                                                                                                                                                                                                                                             | 29/11/2017   | 23/04/2018 | SmPC and PL     |                                                          |
| PSUSA/962/2 | PeriodicSafetyUpdateEUSingle assessment-                                                                                                                                                                                                                                                                                                                                                                                                                                              | 23/03/2017   | 18/05/2017 | SmPC and PL     | Refer to Scientific conclusions and grounds recommending |

<div style=\"page-break-after: always\"></div>

| 01607       | desloratadine                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |            |            |                    | thevariationtotermsoftheMarketingAuthorisation(s)'for PSUSA/962/201607.                                                                                                                                        |
|-------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|--------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| IB/0012     | B.II.f.1.b.1-Stability of FP-Extension of the shelf lifeof thefinishedproduct-Aspackagedforsale (supported byreal time data)                                                                                                                                                                                                                                                                                                                                                                                                                          | 16/05/2017 | 23/04/2018 | SmPC               |                                                                                                                                                                                                                |
| IAIN/0011/G | This was an applicationfor a group ofvariations. A.7-Administrativechange-Deletionof manufacturingsites B.II.b.2.c.1-Change to importer,batch release arrangements andquality control testing of theFP- Replacementoradditionofamanufacturer responsibleforimportation and/orbatchrelease- Notincludingbatchcontrol/testing B.II.b.2.c.1-Change to importer,batch release arrangements and quality control testing of the FP - Replacementoradditionofamanufacturer responsibleforimportation and/orbatchrelease- Not including batch control/testing | 17/02/2017 | 18/05/2017 | Annex II and PL    |                                                                                                                                                                                                                |
| IAIN/0010   | B.IIl.1.a.1-Submissionof anew/updatedor deletionofPh.Eur.CertificateofSuitabilitytothe relevant Ph.Eur.Monograph-New certificate from analreadyapprovedmanufacturer                                                                                                                                                                                                                                                                                                                                                                                   | 16/12/2016 | n/a        |                    |                                                                                                                                                                                                                |
| R/0008      | Renewalofthemarketingauthorisation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   | 15/09/2016 | 11/11/2016 | SmPC and Labelling | Based on the review of data on quality, safety and efficacy, theCHMPconsideredthatthebenefit-riskbalanceof DesloratadineActavisintheapprovedindicationremains favourableandthereforerecommendedtherenewalofthe |

<div style=\"page-break-after: always\"></div>

|           |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |            |            |                       | marketing authorisation with unlimited validity.   |
|-----------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|-----------------------|----------------------------------------------------|
| N/0007    | Minor change in labelling or package leaflet not connected with the SPC (Art.61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                                                                   | 02/02/2016 | 11/05/2016 | PL                    |                                                    |
| IB/0006   | C.I.2.a-Changein theSPC,Labelling orPL ofa generic/hybrid/biosimilar products following assessmentofthesamechangeforthereference product-Implementation of change(s)for whichNO new additional dataisrequired tobesubmittedby the MAH                                                                                                                                                                                                                                                                                             | 14/10/2015 | 11/05/2016 | SmPC, Annex II and PL |                                                    |
| IB/0005   | C.I.2.a-Change in the SPC,Labelling or PL of a generic/hybrid/biosimilarproductsfollowing assessmentof thesamechangeforthereference product - Implementation of change(s) for which NO new additional dataisrequired tobesubmittedby the MAH                                                                                                                                                                                                                                                                                      | 04/06/2015 | 11/05/2016 | SmPC andPL            |                                                    |
| IB/0004/G | This was an applicationfor a group of variations. C.I.2.a-Changein theSPC,Labelling orPL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional dataisrequired tobesubmittedby the MAH C.I.2.a-Changein theSPC,Labelling orPL of a generic/hybrid/biosimilar products following assessmentofthesame changeforthereference product-Implementation of change(s)for whichNO newadditional dataisrequiredtobesubmittedby | 30/04/2015 | 11/05/2016 | SmPC and PL           |                                                    |

<div style=\"page-break-after: always\"></div>

|           | the MAH                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |            |            |                        |           |
|-----------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|------------|------------------------|-----------|
| IAIN/0003 | C.I.8.a-Introduction of or changes to a summary of Pharmacovigilancesystem-ChangesinQPPV (including contact details)and/or changesin the PSMF location                                                                                                                                                                                                                                                                                                                                                         | 16/04/2015 | n/a        |                        |           |
| N/0002    | Updateof thepackageleafletwithrevisedcontact detailsoflocalrepresentativeforGreece,Italyand Portugal. Minor change in labelling or package leaflet not connected with the SPC(Art.61.3 Notification)                                                                                                                                                                                                                                                                                                           | 27/08/2014 | 16/03/2015 | PL                     |           |
|           | This was an application for a group of variations. B.II.b.1.b-Replacement or addition of a manufacturing site fortheFp-Primarypackaging site B.II.e.1.b.1-Change in immediate packaging of the finishedproduct-Changeintype/additionof anew container - Solid, semi-solid and non-sterile liquid pharmaceutical forms B.II.e.5.a.1 -Change in pack size of the finished product - Change in the number of units (e.g. tablets,ampoules,etc.）in a pack-Change within therange of thecurrently approvedpacksizes | 10/03/2014 | 16/03/2015 | SmPC, Labelling and PL | IB/0001/G |